Serotonergic agents in the treatment of hypothalamic obesity syndrome: A case report

International Journal of Eating Disorders

Volumn 20, Issue 1, 1996, Pages 111-113

  Jordaan, Gerhard P ^a,b   Roberts, Mimi C ^b   Emsley, Robin A ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; FLUOXETINE;

ADULT; ARTICLE; BODY WEIGHT; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS DISEASE; MALE; OBESITY; PRIORITY JOURNAL;

ADULT; BODY WEIGHT; BRAIN DAMAGE, CHRONIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FENFLURAMINE; FLUOXETINE; HUMANS; HYPERPHAGIA; HYPOTHALAMIC DISEASES; MALE; OBESITY; SEROTONIN UPTAKE INHIBITORS; TREATMENT FAILURE;

EID: 0030018905     PISSN: 02763478     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-108X(199607)20:1<111::AID-EAT13>3.0.CO;2-7     Document Type: Article

References (12)

1. Anand, B. K. (1962). Nervous regulation of food intake. Physiology Review, 41, 677-708.
2. Blundell, J. E. (1982). Neuroregulators and feeding: Implications for the pharmacological manipulation of hunger and appetite. Reviews in Pure and Applied Pharmacological Sciences, 3, 381-462.
3. Blundell, J. E. (1990). Appetite disturbance and the problems of overweight. Drugs, 39 (Suppl. 3), 1-19.
4. Borsini, F., Bendotti, C., Alleoti, A., Samanin, R., & Garattini, S. (1982). d-Fenfluramine and d-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain. Pharmacological Research Communications, 14, 671-678.
5. Bray, G. A., & Gallagher, T. F. (1975). Manifestations of hypothalamic obesity in man: A comprehensive investigation of eight patients and a review of the literature. Medicine, 54, 301-330.
6. Garattini, S., Mennini, T., & Samanin, R. (1989). Reduction of food intake by manipulation of central serotonin: Current experimental results. British Journal of Psychiatry, 155 (Suppl. 8), 41-51.
7. Leibowitz, S. F. (1990). The role of serotonin in eating disorders. Drugs, 39 (Suppl. 3), 33-48.
8. Leibowitz, S. F., Weiss, G. P., & Shor-Posner, G. (1987). Medial hypothalamic serotonin in the control of eating behaviour. International Journal of Obesity, 11 (Suppl. 3), 110-123.
9. Leibowitz, S. F., Weiss, G. F., & Shor-Posner, G. (1988). Hypothalamic serotonin: Pharmacological, biochemical and behaviour analyses of its feeding-suppressive action. Clinical Neuropharmacology, 11 (Suppl. 1), S51-S71.
10. Lemberger, L., Bergstrom, R. F., Wolen, R. L , Farid, N. A., Enas, G. G., & Aronoff, G. R. (1985). Fluoxetine: Clinical pharmacology and physiologic disposition. Journal of Clinical Psychiatry, 46, 14-19.
11. Stellar, E. (1954). The physiology of motivation. Psychological Review, 61, 5-22.
12. Stricker, E. M. (1978). Hyperphagia. New England Journal of Medicine, 298, 1010-1013.